Influence of monoolein on progesterone transdermal delivery

abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules.

Saved in:
Bibliographic Details
Main Authors: Quintão,Wanessa de Souza Cardoso, Matos,Breno Noronha, Reis,Thaiene Avila, Barreto,Lívia Cristina de Sá, Gratieri,Taís, Gelfuso,Guilherme Msrtins
Format: Digital revista
Language:English
Published: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2015
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1984-82502015000400923
record_format ojs
spelling oai:scielo:S1984-825020150004009232016-03-30Influence of monoolein on progesterone transdermal deliveryQuintão,Wanessa de Souza CardosoMatos,Breno NoronhaReis,Thaiene AvilaBarreto,Lívia Cristina de SáGratieri,TaísGelfuso,Guilherme Msrtins Monoolein/influence/transdermal therapy Progesterone/transdermal delivery Progesterone/skin retention Hormonal replacement/transdermal therapy Skin permeation. abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules.info:eu-repo/semantics/openAccessUniversidade de São Paulo, Faculdade de Ciências FarmacêuticasBrazilian Journal of Pharmaceutical Sciences v.51 n.4 20152015-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923en10.1590/S1984-82502015000400018
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Quintão,Wanessa de Souza Cardoso
Matos,Breno Noronha
Reis,Thaiene Avila
Barreto,Lívia Cristina de Sá
Gratieri,Taís
Gelfuso,Guilherme Msrtins
spellingShingle Quintão,Wanessa de Souza Cardoso
Matos,Breno Noronha
Reis,Thaiene Avila
Barreto,Lívia Cristina de Sá
Gratieri,Taís
Gelfuso,Guilherme Msrtins
Influence of monoolein on progesterone transdermal delivery
author_facet Quintão,Wanessa de Souza Cardoso
Matos,Breno Noronha
Reis,Thaiene Avila
Barreto,Lívia Cristina de Sá
Gratieri,Taís
Gelfuso,Guilherme Msrtins
author_sort Quintão,Wanessa de Souza Cardoso
title Influence of monoolein on progesterone transdermal delivery
title_short Influence of monoolein on progesterone transdermal delivery
title_full Influence of monoolein on progesterone transdermal delivery
title_fullStr Influence of monoolein on progesterone transdermal delivery
title_full_unstemmed Influence of monoolein on progesterone transdermal delivery
title_sort influence of monoolein on progesterone transdermal delivery
description abstract This work aimed to investigate in vitro the influence of monoolein (MO) on progesterone (PG) transdermal delivery and skin retention. Information about the role of MO as an absorption enhancer for lipophilic molecules can help on innovative product development capable of delivering the hormone through the skin in a consistent manner, improving transdermal therapy of hormonal replacement. MO was dispersed in propylene glycol under heat at concentrations of 0% (control), 5% w/w, 10% w/w and 20% w/w. Then, 0.6% of PG (w/w) was added to each formulation. Permeation profile of the hormone was determined in vitro for 48 h using porcine skin in Franz diffusion cells. PG permeation doubled when 5% (w/w) of MO was present in formulation in comparison to both the control and higher MO concentrations (10% and 20% w/w). An equal trend was observed for PG retention in stratum corneum (SC) and reminiscent skin (E+D). PG release rates from the MO formulations, investigated using cellulose membranes, revealed that concentrations of MO higher than 5% (w/w) hindered PG release, which indeed negatively reflected on the hormone permeation through the skin. In conclusion, this work demonstrated the feasibility of MO addition (at 5% w/w) in formulations as a simple method to increase transdermal PG delivery for therapies of hormonal replacement. In contrast, higher MO concentrations (from 10% to 20% w/w) can control active release, and this approach could be extrapolated to other lipophilic, low-molecular-weight molecules.
publisher Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
publishDate 2015
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502015000400923
work_keys_str_mv AT quintaowanessadesouzacardoso influenceofmonooleinonprogesteronetransdermaldelivery
AT matosbrenonoronha influenceofmonooleinonprogesteronetransdermaldelivery
AT reisthaieneavila influenceofmonooleinonprogesteronetransdermaldelivery
AT barretoliviacristinadesa influenceofmonooleinonprogesteronetransdermaldelivery
AT gratieritais influenceofmonooleinonprogesteronetransdermaldelivery
AT gelfusoguilhermemsrtins influenceofmonooleinonprogesteronetransdermaldelivery
_version_ 1756437797854511104